Word: ernstli
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...that such a step would hurt the agency's standing. He added, however, that director of enforcement Stephen Cutler would run the probe anyway. Bush last month named two other accounting executives to empty seats on the SEC: Paul Atkins, a partner with Pricewaterhouse Coopers, and Cynthia Glassman of Ernst & Young...
...that such a step would hurt the agency's standing. He added, however, that director of enforcement Stephen Cutler would run the probe anyway. Bush last month named two other accounting executives to empty seats on the sec: Paul Atkins, a partner with Pricewaterhouse Coopers, and Cynthia Glassman of Ernst & Young. These rookies, like Pitt, face a rough season. "There could be other Enron-like situations out there," says Arthur Levitt, the activist former sec chairman. "Financial legerdemain from seduced audit committees, compromised accountants and inadequate standards could certainly crop up again at other U.S. companies." At the moment...
...anthrax worries gave Caroline Ernst, director of e-commerce at FootSmart, a health-care products firm based in Norcross, Ga., the idea to tell customers by e-mail that the company's catalog was in the mail. Result: a 20% increase in sales. More e-mail ads now contain songs or video clips, such as the messages, with a 30-sec. trailer, promoting the Kevin Costner film Thirteen Days. If you have a microphone and speakers on your computer, clicking on links in some e-mail messages will connect you to a call center where sales reps can answer your...
...capital losses. Consider selling the dogs in your portfolio by Dec. 31. You can use capital losses to offset capital gains, plus as much as $3,000 of ordinary income each year. Suggests Barbara Raasch, a partner at Ernst & Young: "If you have $10,000 of capital gains from mutual funds, look in your portfolio for losses of up to $13,000 and get a tax refund, in essence, by recognizing those losses and selling the security by the end of the year...
This kind of deal is "a model we're likely to see more of as big pharmas and big biotechs try to incorporate these new technologies into their drug-discovery programs," says Ernst & Young analyst Scott Morrison. And in this case it seems to be working. CuraGen has presented Bayer with 24 targets for drug development...